Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Hepatectomy × Clear all

NCT05250843 2023-10-13

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04025437 2019-09-04

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular